BESREMi
ROPEGINTERFERON ALFA-2B
- Strength
- 500 ug/mL
- Form
- Injection
- Class
- Interferon alfa-2b
PharmaEssentia USA
Not stocked by us — reference only
ROPEGINTERFERON ALFA-2B
Listed by PharmaEssentia USA
| Dosage form | Injection, Solution |
|---|---|
| Route | Subcutaneous |
| Drug class | Interferon alfa-2b |
| Approval route | BLA — biologic licence |
| NDC code | 73536-511 |
| FDA application | BLA761166 |
| RxNorm concept | 2587064 |
| Package sizes listed | 1 |
| Marketed since | June 2026 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
ROPEGINTERFERON ALFA-2B
PharmaEssentia USA
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.